1岁6月龄男性患儿，4月龄时发现持续尿糖阳性，伴多饮、多尿、生长迟缓，辅助检查提示患儿存在低比重尿、贫血、低钾血症、低钠血症、低镁血症、代谢性酸中毒、糖尿、氨基酸尿、钾排泄分数增高、肾小管磷重吸收率降低，头颅、胸部及右手腕X线提示肾性佝偻病改变，裂隙灯检查观察到角膜出现大量结晶，基因检查示CTNS基因存在可疑致病性纯合突变c.922G>A(p.Gly308Arg)，该患儿最终诊断为胱氨酸贮积症。治疗初期予对症支持治疗，维持内环境稳定，确诊后特异性应用半胱胺酒石酸胶囊行清除胱氨酸治疗。该文报道了1例CTNS基因突变致胱氨酸贮积症患儿，对该病病因、临床特征、诊疗等进行归纳总结，为该病的早期诊断、治疗及后续研究提供参考依据。
Abstract
A boy, aged 1 year and 6 months, was found to have persistent positive urine glucose at the age of 4 months, with polydipsia, polyuria, and growth retardation. Laboratory examinations suggested that the boy had low specific weight urine, anemia, hypokalemia, hyponatremia, hypomagnesemia, metabolic acidosis, glycosuria, acidaminuria, increased fractional excretion of potassium, and decreased tubular reabsorption of phosphate. X-ray examinations of the head, thorax, and right hand showed changes of renal rickets. The slit-lamp examination showed a large number of cystine crystals in the cornea. The genetic testing showed a suspected pathogenic homozygous mutation of the CTNS gene, C.922g>A(p.Gly308Arg). The boy was finally diagnosed with cystinosis. At the beginning of treatment, symptomatic supportive treatment was given to maintain the stability of the internal environment, and cysteamine tartaric acid capsules were used after diagnosis to remove cysteine. This article reported a case of cystinosis caused by CTNS gene mutation and summarized the etiology, clinical features, diagnosis, and treatment of this disease, which can provide a reference for the early diagnosis, treatment, and subsequent study of the disease.
关键词
胱氨酸贮积症 /
CTNS基因 /
幼儿
Key words
Cystinosis /
CTNS gene /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Nesterova G, Gahl WA. Cystinosis: the evolution of a treatable disease[J]. Pediatr Nephrol, 2013, 28(1): 51-59. PMID: 22903658. PMCID: PMC3505515. DOI: 10.1007/s00467-012-2242-5.
2 Emma F, Nesterova G, Langman C, et al. Nephropathic cystinosis: an international consensus document[J]. Nephrol Dial Transplant, 2014, 29(Suppl 4): iv87-iv94. PMID: 25165189. PMCID: PMC4158338. DOI: 10.1093/ndt/gfu090.
3 Elmonem MA, Veys KR, Soliman NA, et al. Cystinosis: a review[J]. Orphanet J Rare Dis, 2016, 11: 47. PMID: 27102039. PMCID: PMC4841061. DOI: 10.1186/s13023-016-0426-y.
4 Veys KR, Elmonem MA, Arcolino FO, et al. Nephropathic cystinosis: an update[J]. Curr Opin Pediatr, 2017, 29(2): 168-178. PMID: 28107209. DOI: 10.1097/MOP.0000000000000462.
5 Ludwig M, Levtchenko E, B?kenkamp A. Clinical utility gene card for: dent disease (dent-1 and dent-2)[J]. Eur J Hum Genet, 2014, 22(11): 1338. PMID: 24619144. PMCID: PMC4200440. DOI: 10.1038/ejhg.2014.33.
6 Yang YJ, Hu Y, Zhao R, et al. First report of CTNS mutations in a Chinese family with infantile cystinosis[J]. ScientificWorldJournal, 2015, 2015: 309410. PMID: 25866837. PMCID: PMC4381850. DOI: 10.1155/2015/309410.
7 马艳艳, 沈延君, 周玲, 等. CTNS基因突变导致幼儿胱氨酸肾病及角膜结晶[J]. 临床儿科杂志, 2016, 34(10): 783-786. DOI: 10.3969/j.issn.1000-3606.2016.10.017.
8 杜娟, 庞芮, 姜艳, 等. 2例胱氨酸病临床特点及其CTNS基因突变[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 469-473. DOI: 10.3969/j.issn.1674-2591.2017.05.007.
9 Ling C, Liu XR, Chen Z, et al. Corneal cystine crystals in cystinosis[J]. Arch Dis Child, 2017, 102(12): 1185. PMID: 28325728. DOI: 10.1136/archdischild-2016-312456.
10 Shotelersuk V, Larson D, Anikster Y, et al. CTNS mutations in an American-based population of cystinosis patients[J]. Am J Hum Genet, 1998, 63(5): 1352-1362. PMID: 9792862. PMCID: PMC1377545. DOI: 10.1086/302118.
11 Kalatzis V, Nevo N, Cherqui S, et al. Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin[J]. Hum Mol Genet, 2004, 13(13): 1361-1371. PMID: 15128704. DOI: 10.1093/hmg/ddh152.
12 Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
13 中华人民共和国国家卫生健康委员会. 糖原累积病(Ⅰ型和Ⅱ型)诊疗指南(2019)[J]. 中国实用乡村医生杂志, 2021, 28(3): 8-10. DOI: 10.3969/j.issn.1672-7185.2021.03.004.
14 梅慧芬, 刘丽. 半乳糖血症诊断方法研究进展[J]. 国际儿科学杂志, 2007, 34(2): 154-156. DOI: 10.3760/cma.j.issn.1673-4408.2007.02.027.
15 向伟, 丁宗一, 郑维, 等. 如何预防小儿维生素D缺乏和维生素D缺乏性佝偻病—浅谈美国儿科学会维生素D摄入量新指南[J]. 中国当代儿科杂志, 2005, 7(6): 530-532.
16 《中华儿科杂志》编辑委员会, 中华医学会儿科学分会儿童保健学组, 全国佝偻病防治科研协作组. 维生素D缺乏性佝偻病防治建议[J]. 中华儿科杂志, 2008, 46(3): 190-191. DOI: 10.3321/j.issn:0578-1310.2008.03.007.
17 杨楠, 韩连书, 叶军, 等. 三例酪氨酸血症Ⅰ型患者的临床表现及基因突变分析[J]. 中华医学遗传学杂志, 2012, 29(6): 648-652. DOI: 10.3760/cma.j.jssn.1003-9406.2012.06.005.
18 Foreman JW. Fanconi syndrome[J]. Pediatr Clin North Am, 2019, 66(1): 159-167. PMID: 30454741. DOI: 10.1016/j.pcl.2018.09.002.
19 Simon RH. Pulmonary complications of cystinosis[J]. J Pediatr, 2017, 183S: S9-S14. PMID: 28343476. DOI: 10.1016/j.jpeds.2016.12.050.
20 Levtchenko E. Endocrine complications of cystinosis[J]. J Pediatr, 2017, 183S: S5-S8. PMID: 28343475. DOI: 10.1016/j.jpeds.2016.12.049.
21 Gaide Chevronnay HP, Janssens V, Van Der Smissen P, et al. A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing[J]. Endocrinology, 2015, 156(6): 2349-2364. PMID: 25811319. PMCID: PMC4430621. DOI: 10.1210/en.2014-1672.
22 Trauner D. Neurocognitive complications of cystinosis[J]. J Pediatr, 2017, 183S: S15-S18. PMID: 28343470. DOI: 10.1016/j.jpeds.2016.12.054.
23 李晓侨, 巩纯秀. 胱氨酸贮积症诊疗进展[J]. 临床儿科杂志, 2020, 38(2): 156-160. DOI:10.3969/j.issn.1000-3606.2020.02.018.
PDF(919 KB)
